These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19046800)

  • 41. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells.
    Lee YK; Lee WS; Hwang JT; Kwon DY; Surh YJ; Park OJ
    J Agric Food Chem; 2009 Jan; 57(1):305-10. PubMed ID: 19093868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
    Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eupatilin exhibits a novel anti-tumor activity through the induction of cell cycle arrest and differentiation of gastric carcinoma AGS cells.
    Choi EJ; Oh HM; Wee H; Choi CS; Choi SC; Kim KH; Han WC; Oh TY; Kim SH; Jun CD
    Differentiation; 2009 Apr; 77(4):412-23. PubMed ID: 19281788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overcoming immune resistance in the tumor microenvironment by blockade of indoleamine 2,3-dioxygenase and programmed death ligand 1.
    Gajewski TF
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1279-83. PubMed ID: 15648949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells.
    Ambike V; Adsule S; Ahmed F; Wang Z; Afrasiabi Z; Sinn E; Sarkar F; Padhye S
    J Inorg Biochem; 2007 Oct; 101(10):1517-24. PubMed ID: 17689613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells.
    Uram Ł; Filipowicz-Rachwał A; Misiorek M; Winiarz A; Wałajtys-Rode E; Wołowiec S
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of cyclooxygenase-2 in breast cancer: review.
    Singh-Ranger G; Salhab M; Mokbel K
    Breast Cancer Res Treat; 2008 May; 109(2):189-98. PubMed ID: 17624587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of PD-L1 Expression by Prostaglandin E
    Goto S; Konnai S; Hirano Y; Kohara J; Okagawa T; Maekawa N; Sajiki Y; Watari K; Minato E; Kobayashi A; Gondaira S; Higuchi H; Koiwa M; Tajima M; Taguchi E; Uemura R; Yamada S; Kaneko MK; Kato Y; Yamamoto K; Toda M; Suzuki Y; Murata S; Ohashi K
    Front Vet Sci; 2020; 7():12. PubMed ID: 32154274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.
    Bell CR; Pelly VS; Moeini A; Chiang SC; Flanagan E; Bromley CP; Clark C; Earnshaw CH; Koufaki MA; Bonavita E; Zelenay S
    Nat Commun; 2022 Apr; 13(1):2063. PubMed ID: 35440553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methoxybenzamide derivative of nimesulide from anti-fever to anti-cancer: Chemical characterization and cytotoxicity.
    Jaragh-Alhadad LA; Ali MS
    Saudi Pharm J; 2022 May; 30(5):485-493. PubMed ID: 35693435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nimesulide and hepatitis: death, transplantation; regulatory failures.
    Prescrire Int; 2008 Feb; 17(93):22. PubMed ID: 18386395
    [No Abstract]   [Full Text] [Related]  

  • 54. Nimesulide induced bullous fixed drug eruption of the labial mucosa.
    Kumaran S; Sandhu K; Saikia UN; Handa S
    Indian J Dermatol Venereol Leprol; 2004; 70(1):44-5. PubMed ID: 17642560
    [No Abstract]   [Full Text] [Related]  

  • 55. Mapping the surface of the cancer cell.
    Nature; 1971 May; 231(5299):148. PubMed ID: 16062599
    [No Abstract]   [Full Text] [Related]  

  • 56. Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
    John N; Schlintl V; Sassmann T; Lindenmann J; Fediuk M; Wurm R; Douschan P; Zacharias M; Kalson L; Posch F; Absenger G; Brcic L; Jost PJ; Terbuch A
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer.
    Svaton M; Drosslerova M; Fischer O; Marel M; Hrnciarik M; Venclicek O; Zuna P; Svoboda M; Blazek J; Bratova M; Mullerova A; Vankova B; Krejci D
    Transl Cancer Res; 2022 Sep; 11(9):3017-3023. PubMed ID: 36237267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition.
    Gómez-Valenzuela F; Escobar E; Pérez-Tomás R; Montecinos VP
    Front Oncol; 2021; 11():686792. PubMed ID: 34178680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The PD-L1 metabolic interactome intersects with choline metabolism and inflammation.
    Pacheco-Torres J; Penet MF; Mironchik Y; Krishnamachary B; Bhujwalla ZM
    Cancer Metab; 2021 Feb; 9(1):10. PubMed ID: 33608051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.